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Abstract 
 
Organ motion as a result of respiration is an important field of research for medical physics. 
Knowledge of magnitude and direction of this motion is necessary to allow for more accurate 
radiotherapy treatment planning. This will result in higher doses to the tumour whilst sparing 
healthy tissue. 
 
This project involved human trials, where the radiation therapy patient’s kidneys were CT 
scanned under three different conditions; whilst free breathing (FB), breath-hold at normal 
tidal inspiration (BHIN), and breath-hold at normal tidal expiration (BHEX). The magnitude 
of motion was measured by recording the outline of the kidney from a Beam’s Eye View 
(BEV). The centre of mass of this 2D shape was calculated for each set using “ImageJ” 
software and the magnitude of movement determined from the change in the centroid’s co-
ordinates between the BHIN and BHEX scans. The movement ranged from, for the left and 
right kidneys, 4-46mm and 2-44mm in the superior/inferior (axial) plane, 1-21mm and 2-
16mm in the anterior/posterior (coronal) plane, and 0-6mm and 0-8mm in the lateral/medial 
(sagittal) plane. From exhale to inhale, the kidneys tended to move inferiorly, anteriorly and 
laterally.  
 
A standard radiotherapy plan, designed to treat the para-aortics with opposed lateral fields was 
performed on the free breathing (planning) CT set. The field size and arrangement was set up 
using the same parameters for each subject. The prescription was to deliver 45 Gray in 25 
fractions. This field arrangement and prescription was then copied over to the breath hold CT 
sets, and the dosimetric differences were compared using Dose Volume Histograms (DVH). 
The point of comparison for the three sets was recorded as the percentage volume of kidney 
receiving less than or equal to 10 Gray. The QUASAR respiratory motion phantom was used 
with the range of motion determined from the human study. The phantom was imaged, 
planned and treated with a linear accelerator with dose determined by film. The effect of the 
motion was measured by the change in the penumbra of the film and compared to the 
penumbra from the treatment planning system. 
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Chapter 1 – Introduction 
Malignant cancer is a disease whereby formerly healthy tissue grows at an unregulated rate 
and invades nearby healthy tissues. These cancers can also spread to other parts of the body 
(metastasize) through the bloodstream and lymphatic system. Radiation therapy is one type 
of treatment for cancer; the others being Chemotherapy, Surgery, Immunotherapy and 
Monoclonal antibody therapy, it can be used by itself, or in combination with the others 
depending on the tumour type and staging. 
 
The treatment of cancer by means of radiation therapy, involves targeting the cancerous 
tissue with ionising radiation from photons or electrons or a combination of both. The 
radiation in the form of photons or charged particles can damage the DNA in the cancer cell 
directly. Or more commonly form free radicals (Hydroxyl –OH) from the water molecules, 
and these go on to damage the cancer cells DNA. All cells have the ability to repair this 
damage, however cancerous cells have a diminished ability to repair compared to healthy 
tissue. This damage to the cancer cell’s DNA will be passed on through cell division and 
accumulate to the point where the cell can no longer function and it will die. 
 
A successful treatment is one in which all the tumour cells are either killed outright or suffer 
reproductive cell death. In addition to this outcome, the irradiation of healthy tissue must be 
kept to a minimum so the functions of these tissues are maintained. It is this factor of 
optimising maximal dose to the tumour while keeping dose to healthy tissue minimal that 
determines the dose to be delivered. Radiation fields are shaped so they treat all of the 
cancerous tissue. These fields are expanded when it is known or assumed that the target may 
move during a treatment (intra-fraction) or during subsequent treatments (inter-fraction). 
 
A standard assumption is that when a radiation therapy patient is being treated, their organs 
and tissues are static. Unfortunately this is not the case.  Many normal body functions cause 
movement of the organs. These include movement of food through the digestive tract, rectal 
and bladder filling and emptying and respiration. Protocols involving diet and emptying or 
filling of the bladder and rectum prior to treatment can be employed to establish day to day 
consistency of the position and size of these organs. Respiration during a radiation therapy 
treatment can cause organs primarily in the abdominal and thoracic regions to undergo 
movement. This can result in the target moving out of the beam and healthy tissue moving 
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into the beam. This will lead to under-dosing of the target and over-dosing of the healthy 
tissue with respect to the treatment plan.  
 
1.1. Imaging Modalities 
There are several imaging modalities that can be employed to quantify the magnitude and 
direction of organ motion due to respiration. There are many factors when deciding which to 
use; cost, time, patient comfort, radiation exposure and accuracy of results. Depending on 
the modality, measurements can be taken before treatment planning, during the radiation 
treatment or after the radiation treatment. Each of the modalities has their advantages and 
disadvantages. 
 
1.1.1. Magnetic Resonance Imaging  
Magnetic resonance imaging (MRI) provides information of the proton density of tissues in 
the human body. (Bushberg J. T., Seibert J. A. et al. 2002) An MRI scanner generates 
magnetic fields which align the magnetic moments of the hydrogen atoms within the patient. 
Pulses of radio frequency then cause these atoms to change their magnetic moments and 
produce a rotating magnetic field which can then be detected by the scanner. The MRI 
machine uses a magnetic field gradient applied in each axis that causes the atoms magnetic 
moments to rotate at different speeds, this provides spatial information. The human body is 
mostly water, each molecule consists of two hydrogen atoms (protons). Consequently, a 
scan shows the different water density within tissues. There is no ionising radiation 
associated with an MRI scan, as only magnetic fields and radio frequency pulses are applied. 
Scan times can be between 20-40 minutes depending on the procedure. The image quality of 
soft tissues is greatest of all the modalities, however due to the long scan times any 
movement can cause data acquisition errors or artefacts which can result in a poorer image 
quality.   
 
Various studies have been conducted using MRI to investigate organ motion due to 
respiration. (Moerland M. A., Van den Bergh A. C. et al. 1994) studied the displacements of 
the left and right kidneys under normal and forced respiration. Due to the long acquisition 
time the resultant images were of poor quality. (Bussels B., Goethals L. et al. 2003) used 
dynamic magnetic resonance imaging on 12 patients to measure the magnitude of motion of 
the pancreas, liver and kidneys. The image sets were obtained in 60 seconds, and the motion 
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could be viewed as a movie loop. (Schwartz L. H., Richuad J. et al. 1994) used fast 
magnetic resonance imaging while patients performed breath holds. The scans were done at 
deep inspiration and deep expiration, as a result the range of motion was found to be larger 
than the previous studies. (Song R., Tipirneri A. et al. 2011) investigated the motion of the 
liver and kidneys in an effort to reduce motion artefacts in gated MRI scans. 
 
1.1.2. Ultrasound 
Ultrasound imaging provides information in real time by use of sound waves produced from 
a piezoelectric transducer. (Bushberg J. T., Seibert J. A. et al. 2002) When these waves 
encounter an interface, or a tissue with a differing density, part of the energy of the wave is 
reflected back as an echo. This echo is received by the transducer, and by knowing the 
strength of the echo, and the time between the original pulse and the echo, spatial 
information can be derived and displayed on a screen. To measure organ motion, ultrasound 
probes require a tracking device to record the probes position in 3 dimensional space while 
it acquires images. There is no ionising radiation associated with an ultrasound scan as only 
acoustic waves, at a frequency of 2-18 MHz, are produced. Scan times can be between 10-
30 seconds depending on site, and operator experience. The image quality is dependant on 
the acoustic properties of the tissues, ultrasound propagates poorly though low density tissue 
like lung. The results from an ultrasound scan are also highly dependant on the skill of the 
operator handling the probe. 
 
The use of ultrasound in studying organ motion due to respiration has been investigated by 
several authors. (Davies S. C., Hill A. L. et al. 1994) used ultrasound to measure organ 
motion in order to design a criterion for a motion test object for use with an MRI. (Kingma 
R., Rohling R. N. et al. 2011) used fiducial markers on a phantom in order to register CT 
and ultrasound images. A clinical study on 3 patients was carried out where displacement of 
the kidney due to respiration was measured.  
 
1.1.3. Computed Tomography 
Computed tomography provides information on the electron density of tissues in the human 
body. (Bushberg J. T., Seibert J. A. et al. 2002) With diagnostic x-ray imaging, the 3D 
volume of a patient is reduced to a 2D projection image, with each point or pixel on that 
image being a representation of the attenuation properties of a ray through the patient from 
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the x-ray source to the detector. With CT an x-ray source and opposing detector are rotated 
around the patient, the detector gathers attenuation information from a 360° rotation, the 
patient couch moves forward and another slice is acquired. The data is then processed using 
filtered back projection to obtain a 2D cross sectional image of the patient for each rotation. 
Scan times are reduced with more modern scanners such as helical or spiral CT, whereby the 
patient couch top is moving at a uniform rate whilst the x-ray source and detector are 
collecting data. Scan times can be between 5-30 seconds depending on site, slice thickness 
and whether the CT is helical or axial. Computed tomography uses ionising radiation, 
therefore there could be ethical issues if extra scans are required using breath hold 
techniques to measure organ motion. The spatial resolution is worse, and contrast resolution 
is better compared to that of regular radiograph. CT scans are susceptible to beam hardening 
artefacts caused by x-rays passing though denser tissue such as bone. The lower end of the 
spectrum is preferentially attenuated resulting in a higher average energy compared to x-rays 
passing through an equivalent thickness of soft tissue. Motion artefacts can cause blurring or 
if severe enough, doubling of the image.  
 
The use of CT as a modality in studying the magnitude and direction of organ motion for 
radiation therapy patients has been popular. As a normal part of their radiation therapy 
planning, patients would need to undergo a CT scan, this would be done while the patient 
was breathing freely. (Balter J. M., Ten Haken R. K. et al. 1996) compared CTs of free 
breathing, breath hold inhalation and exhalation for changes in the position and volume of 
the lung liver and kidneys. It was found that artefacts in the free breathing scan caused by 
the CT sampling as the organ moved can give misleading information of the volume, and 
volume dependant criteria as dose-volume histograms. (Frazier R. C., Vicini F. A. et al. 
2004) also compared free breathing and breath hold CT scans, and used a radiopaque marker 
in a catheter at the medial field edge to determine the magnitude and direction of motion.  
 
(Menon G., Pudney D. et al. 2011) used CT imaging on a wax breast phantom with cork 
lung inserts. Four different breast planning techniques were delivered to the phantom whilst 
static, and with 1 and 2cm amplitude oscillations to simulate breathing. Using film to 
measure the dose it was found that the dose delivered to the moving phantom was within 5% 
of that delivered to the static. 
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1.1.4. 4D Computed Tomography 
4-Dimensional Computed Tomography (4DCT) uses the same technology to gather 
information about the electron density of the human body. In 4DCT each slice is imaged 
multiple times at the different points of a breathing cycle. This is monitored using an 
infrared reflective marker placed on the patient’s chest that moves as the patient breathes. 
Data is processed in the same way as regular CT.  Each slice is sorted into a different CT set 
depending on which part of the breathing cycle it came from. The CT set can now be viewed 
at any stage during the respiration cycle, or viewed with all sets averaged together. 4DCT 
relies on a regular and reproducible breathing cycle over the course of a full scan which lasts 
up to 2 minutes, however breathing is not perfectly periodic. The generation of images in 
4DCT is the same as regular CT therefore the image quality is the same. Beam hardening 
artefacts would still occur, however motion artefacts caused by respiration would be 
dramatically reduced or eliminated all together.  
 
4DCT is the most recent radiation therapy imaging development, and is currently the subject 
of a lot of research. (Brandner E. D., Heron D. et al. 2006) studied the motion of the 
pancreas, liver, spleen and kidneys from 4DCT scans of 18 patients. The results led to a 
reduction of the planning target volume (PTV) which would have reduced toxicity to 
surrounding healthy tissue. (Brandner E. D., Wu A. et al. 2006) conducted a further similar 
study on 13 patients coming to the same conclusion. (Van Sorsen de Koste J. R., Senan S. et 
al. 2006) analysed the scans of 54 patients during quiet uncoached respiration. They found 
that there was large inter-patient variation in kidney motion and suggested that respiration 
coaching could be useful for radiation therapy patient imaging and treatment. 
 
 
1.1.5. Other Imaging Modalities 
Megavoltage (MV) or portal imaging is a modality similar to diagnostic kV imaging 
however MV photons generated from a linear accelerator are used. The main benefit being 
the patient can be imaged in their radiation therapy position. A patient can have these 
images taken before, during and after their treatment. Images can be taken with the 
treatment aperture and treatment delivered immediately after. This provides confirmation of 
what is seen in the image is what was treated. Megavoltage photons interact with matter in a 
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different way than diagnostic kilovoltage (kV) photons, and consequently yield much poorer 
contrast resolution of soft tissues. (Reinstein L. E., Amols H. I. et al. 1987) 
 
Modern linear accelerators now have the ability to take kV images with the use of On-Board 
Imaging (OBI). A kV source and detector plate are mounted on the linear accelerator on 
arms that are orthogonal to the treatment beam. kV Images can be taken before and after 
treatment to verify the position of  certain anatomical structures. The image’s quality is the 
same as a diagnostic radiograph. OBI can also be used in a fluoroscopic mode where 
internal structures, and their movement can be viewed in real time. (Willis D. J., Kron T. et 
al. 2009) used OBI to take images of the kidneys and found that the information they 
acquired would be advantageous where respiratory motion was a concern. The dose from a 
single kV OBI image was measured on an anthropomorphic phantom and found to be 17 
times less than MV portal imaging.  
 
OBI also has the ability to produce Cone Beam Computed Tomography (CBCT). Here the 
kV source and detector rotate around the patient in a single arc which takes about 60 
seconds. The source produces a fan beam covering the area to be imaged, and they are 
recorded by the detector as a series of 2D radiographs. Using a similar back projection 
technique as regular CT, computers can reconstruct the data as a 3D volume, and cross 
sectional images of the patient can be viewed. Having a CT data set of the patient, who is in 
their set up position immediately prior to treatment, is extremely useful. Organ position and 
volumes can be measured, as they can with MV and kV imaging, and treatment adjusted if 
necessary. This is known as Image Guided Radiation Therapy (IGRT). CBCT can be used to 
reduce inter-fraction setup errors. (Beltran C., Pai Panandiker A. S. et al. 2010) found that 
lateral, longitudinal and vertical setup margins of 5.4, 5.6, and 5.9mm reduced to 1.5, 2.1 
and 2.7mm when daily CBCT was incorporated. 
 
All three of these imaging techniques are useful with detecting differences in organ position 
or size on the day of treatment compared to their planning CT.  
 
1.2. Organ Motion Studies 
Organs in the abdominal and thoracic cavity undergo significant motion due to respiration. 
When treating cancer with radiation therapy, it is extremely important to know where the 
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tumour and healthy organs are so they can be targeted or avoided affectively. Organ motion 
due to respiration introduces an unavoidable error into the radiation therapy process. 
Understanding and quantifying the magnitude of this error has been the subject of numerous 
studies using various imaging techniques.  The movement ranges observed using some of 
the techniques outlined above are included in Table 1.1.   
Table 1-1: Summary of magnitude of kidney motion due to respiration in literature 
Reference Imaging 
Modality 
Structure Breath 
Type 
Movement 
Range (mm) 
# of patients 
Moreland et al. 
1994 
MRI Left Kidney (Normal) 
{Forced} 
(2-24) 
{10-66} 
(13)       
{11} 
Right Kidney (Normal) 
{Forced} 
(4-35) 
{10-86} 
(13)       
{11} 
Bussels et al. 
2003 
MRI Left Kidney Normal 16.9±6.7 12 
Right Kidney Normal 16.1±7.9 12 
Song et al. 2011 MRI Left Kidney Normal 4.8-13.9 10 
Right Kidney Normal 4.4-15.1 10 
Schwartz et al. 
1994 
MRI Left Kidney Forced 6-39 13 
Right Kidney Forced 3-39 14 
Davies et al 
1994 
Ultrasound Kidneys Normal 5-16 9 
Kingma et al. 
2001 
Ultrasound Kidneys Normal 11.6-18.7 3 
Balter et al 1996 CT Left Kidney Normal 18±6 9 
Right Kidney Normal 18±6 9 
Frazier et al 
2004 
CT Catheter 
above kidney 
Normal 3-11 10 
Brandner et al 
2006 
4DCT Left Kidney Normal 11 13 
Right Kidney Normal 13 12 
Brandner et al 
2006 
4DCT Left Kidney Normal 12 18 
Right Kidney Normal 13 17 
Van Sorensen 
de Koste et al 
2006 
4DCT Left Kidney Normal 9.8±5.0 54 
Right Kidney Normal 9.0±4.5 54 
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1.3. Research Objectives. 
The objective of this research was to measure the magnitude of kidney motion due to 
respiration.  This information was used to deliver radiation treatment to a respiratory motion 
phantom.  The dose measured was compared to that calculated on the planning system. 
More detailed objectives were: 
• To determine the magnitude and direction of motion of the kidneys of human 
volunteers using breath hold CT scans. 
• To create a plan treating the para-aortics with lateral fields on the free-breathing 
scan, and copy this plan over to the two breath hold scans 
• To calculate the dosimetric difference between the 3 scans. 
• To CT and plan the QUASAR respiratory motion phantom 
• To deliver radiation therapy to the QUASAR phantom using a range of motion 
determined from the human study. 
• To determine the dosimetric differences between plan and treatment and quantify 
errors induced from phantom motion. 
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Chapter 2 – Background 
Computed tomography was first introduced in 1972 with the EMI Mark 1 scanner, though 
the mathematics behind the filtered back projection was developed by Johann Radon (Radon 
J. 1986) in 1917. It was not until the 1970’s that the computing power required for those 
calculations was developed which enabled it to be used as an imaging modality. Since then, 
CT scanner design has gone through several generations in design and technological 
advancements.  
 
2.1.  Computed Tomography  
2.1.1. CT Generations 
The first generation of CT scanner employed a “translate and rotate” method. That is, a 
pencil beam of stationary x-rays were projected through a patient, the source then translated 
and the procedure repeated. When the source had translated across the entire field of view 
(FOV), the entire assembly is rotated and the process repeated. (Figure 2.1) The scan was 
time consuming but yielded better image quality than 2
nd
 generation scanners due to the 
pencil beam geometry. Because a small volume was being irradiated, photons scattered 
outside the primary beam would not be picked up by the detector.  
Figure 2-1 First generation CT showing the “translate and rotate” method of image acquisition. Taken 
from (Bushberg J. T., Seibert J. A. et al. 2002) 
 
 
Second generation CT scanners utilised an x-ray fan beam and a linear array of detectors, 
negating the need for the translation movement in first generation CT scanners. This 
produced scan times that were 15 times quicker, however the rejection of scattered radiation 
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was less and greater exposure times were needed to gather more data to achieve the same 
image quality as the previous generation. (Bushberg J. T., Seibert J. A. et al. 2002) 
 
Where previous generations scanners collected their information while stationary then 
moved to a new location and collected more, third generation scanners mechanically joined 
the x-ray tube and detector array together enabling them to collect data whilst the unit was 
being rotated around the patient. (Figure 2.2) The detector panels increased in size allowing 
for wider x-ray fan beams to encompass the entire patient. Due to the elimination of the 
translation stage, scan times per slice were reduced to less than 5 seconds, 3 times faster 
than 2
nd
 generation scanners. (Bushberg J. T., Seibert J. A. et al. 2002) 
 
Forth generation scanners introduced a stationary 360° ring detector around the patient. 
(Figure 2.2) This configuration eliminated the presence of ring artefacts, however it required 
many more detectors. Modern 4
th
 generation scanners have around 4,800 individual 
detectors. As the detector is now stationary, it is able to collect information from multiple 
rays as the source sweeps across the patient. 
Figure 2-2 Third and forth generation CT showing the changes to detector configuration. Taken from 
(Bushberg J. T., Seibert J. A. et al. 2002) 
 
The fifth generation scanner is a novel redesign of the machine as it does away with the 
standard x-ray tube. An electron beam is produced behind and inline with the patient which 
is then steered into a target array around the patient. These scanners are primarily of interest 
to cardiologists as their scan times of the heart can be as little as 50 ms. (Bushberg J. T., 
Seibert J. A. et al. 2002) 
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Up until now, previous scanners (5
th
 generation being the exception) had the mechanical 
limitation of the wires from the rotating x-ray tube and/or detector being connected to 
stationary electronics. This meant the gantry would have to stop after each rotation (slice) 
then collect more data rotating back in the other direction. The introduction of slip ring 
technology, enabled the gantry to continuously rotate in one direction. Without having to 
stop and reverse the direction of the gantry every rotation, inertia was no longer an issue, 
therefore gantry speeds could increase and scan times be reduced.  Sixth generation scanners 
were now able to collect data continuously while that patient was moving through the bore, 
these are helical scanners, their names derived from the helical path the source takes around 
the patient. Scan times for an entire abdomen are now less than 30 seconds, within the realm 
of a single breath hold for patients without impaired respiratory function.  
 
An advance in the technology of the detector array is the cause of seventh generation 
scanners. Previously slice thickness was determined by the size of the collimator or the 
detector, now with multiple detector arrays, the size of the detector determines the slice 
thickness. This means that less x-ray photons are needed to acquire an image of equal 
quality than previous generations. With a multiple detector array, the minimum slice widths 
can be added together to produce image sets with slices of 2, 3 or 4 times the original slice 
thickness, all from the one scan. 
 
2.1.2. CT in Radiation Therapy 
The introduction of CT into radiation therapy treatment planning was a major step in 
improving patient treatment. Previously a single patient contour was taken with a wire, 
radiographs were used to shape the fields, and determine organs at risk. This was known as 
2D planning. CT based planning allowed a three dimensional representation of the patients 
body to be viewed and planned. Targets and organs at risk can be contoured in 3D giving the 
radiation oncologists greater confidence. In addition to these benefits, CT data provides 
attenuation information in Hounsfield units which can be converted into electron density. 
Calculation of dose deposited by ionising radiation requires the electron density of the 
medium being irradiated. CT based 3D planning can now be used to display the calculated 
dose distributed on the patients CT set.  
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2.1.3. Dose Considerations of CT 
CT scanners produce ionising radiation, and depending on the site imaged, this can lead to a 
dose to the patient of up to 20mSv. (Brennner D. J. and Hall E.J. 2007) However the French 
Academies report (Tubiana M., Aurengo A. et al. 2005) concluded that doses of 150mSv 
and less have not been shown to increase the incidence of cancer to a clinically significant 
level. The benefits a CT scan can provide a radiation therapy patient are far greater than the 
risks associated with ionising radiation. Also the dose a patient would receive from a course 
of radiation therapy would be several orders of magnitude greater than that of the CT scan. 
 
2.2. Anatomy and Physiology 
2.2.1. Kidney Location and Attributes 
The kidneys have several functions in the human body, the main function is to filter out and 
remove waste from the bloodstream. The kidneys are located in the abdominal cavity 
between the 12
th
 thoracic (T12) vertebrae and the 3
rd
 lumbar (L3) vertebrae, with the right 
kidney being slightly lower than the left due to it being underneath the liver. A typical adult 
kidney length is 11.2cm for the left, and 10.9cm for the right, widths of 5.8cm and 5.7cm 
and a volume of 146cm
3
 and 134cm
3
 respectively. (Emamian S. A., Nielsen M. B. et al. 
1993)  The kidney has one of the lowest tolerances to radiation of any organ in the human 
body (Emami B., Lyman J. et al. 1991) The TD 50/5 (50% probability of a radiation induced 
complication within 5 years) for the whole kidney volume is 2800 cGy. The bladder in 
comparison is 8000 cGy. 
 
2.2.2. Mechanics of Respiration 
A respiratory cycle consists of two stages, inspiration and expiration. Inspiration occurs 
when the diaphragm, the large muscle that separates the thoracic and abdominal cavities, 
contracts and pulls down creating a negative pressure inside the lungs and air is 
consequently drawn into them. The thoracic cavity and lungs increase in size and volume. 
During expiration the diaphragm relaxes and moves back up reducing the size of the 
thoracic cavity and assisting with the expulsion of air from the lungs.  The kidneys, located 
underneath the diaphragm, move in the same direction; predominantly inferiorly during 
inspiration and superiorly during expiration.  
 
 13
2.3. Radiation Therapy Treatment Planning Process 
For a patient to be treated with radiation therapy there are many steps prior to the actual 
treatment which need to be taken to ensure the best possible outcome. (Figure 2.3) 
Depending on the type and stage of the cancer, radiation therapy could be used solely, in 
conjunction with other therapies or not at all. Other therapies include chemotherapy, 
surgery, immunotherapy and monoclonal antibody therapy. The patient will be reviewed by 
a Radiation Oncologist and they will determine the imaging scans to be done. A CT scan 
will always be done for planning purposes, an MRI could also be requested due to its 
superior contrast of soft tissue, and a positron emission tomographic (PET) scan could be 
requested due to its ability to detect the microscopic and nodal extent of the disease.  
 
The CT scan is known as the simulation stage, here the patient will be set up exactly the 
same way they would for their treatment, using the same support and immobilisation 
devices. For radiation therapy to be effective, the set up for every treatment needs to be the 
same as for the CT scan. Once the scan is finished, the 3D data set is exported to the 
Radiation Treatment Planning System. (RTPS)  
 
The RTPS is sophisticated software that allows the radiation oncologist to view a virtual 
representation of the patient’s body. They then contour the tumour volume and any organs at 
risk (OAR). The oncologists would then prescribe a dose to the target and dose limits to the 
OAR. Using the software, radiation therapists will design a treatment to meet the 
oncologist’s prescription. Once reviewed and signed off, the plan will be sent to the linear 
accelerator. Depending on the department, and the complexity of the treatment, quality 
assurance of the plan will be verified by a medical physicist before treatment commences. 
 
The patient will be set up inside a linear accelerator bunker on the treatment couch, in the 
same position that they were scanned and planned on. Pre-treatment images will be taken to 
verify the patient is in the correct position, and once the radiation therapists and oncologists 
are satisfied, treatment will commence. Depending on the treatment technique, a single 
faction can last between 10 – 30 minutes. The patient will then return every day to deliver 
the remainder of their fractions. The patient’s progress and health will be monitored by 
specialists during the course of their treatment and they will have follow up appointments 
after it is completed. 
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Figure 2-3 Steps in Radiation Therapy.  Not every patient will require all steps, nor will they always be 
in the order indicated. Adapted from p119 (Williams J R. and Twaites D I. 2000) 
 
2.3.1. Target Localisation 
There are several terms used to describe the volumes outlined by the radiation oncologists 
during the planning stage. These are set out and described by the International Commission 
of Radiation Units and Measurements (ICRU) in report 50 and supplement report 62. 
(Figure 2.4) The Gross Tumour Volume (GTV) is the volume that contains visibly or 
clinically detectable tumour. This can be done by a physical examination or visualised by 
one of the imaging modalities. Some plans may not have a GTV if the main tumour volume 
has been excised by surgery. The Clinical target Volume (CTV) is the volume which 
encompasses the GTV to include any microscopic cancerous involvement which can not be 
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felt in an examination or imaged. The Internal Target Volume (ITV) expands on the 
previous volumes to take into account the movement of the patient during treatment. For 
example the heart beating, movement of the intestinal tract and movement caused by 
respiration The size of the margin of the ITV will depend on the treatment site and if 
measures are taken to reduce the effects of the movement like respiration gating. (See 
section 2.4). The Planning Target Volume (PTV) is an expansion on the ITV to account for 
inaccuracies in treatment delivery. Treatment inaccuracy tolerances would vary on treatment 
site and department protocols. Improvements in patient setup, the use of pre-treatment 
imaging and correction and tighter tolerances for physics quality assurance tests, can lead to 
reduced margins for the PTV. Organs at Risk (OAR) are healthy organs close to the 
treatment site which radiation dose should be avoided or limited. Dose constraints are placed 
on these organs during the planning stage and the amount of dose these OAR are permitted 
to receive varies greatly with tissue type. (Emami B., Lyman J. et al. 1991) The ICRU 
reports also give recommendations and guidelines on where to place the reportable dose 
reference point. It should be inside the PTV in a place of uniform dose away from any tissue 
inhomogeneity and the intersection of beam axes if possible. 
Figure 2-4 Treatment regions in radiation therapy as defined by ICRU 50 and 62. 
 
2.4. Respiration Gating 
The size and shape of a radiation field does not change during non-modulated treatment, 
therefore it needs to be large enough to envelop the entire tumour during the respiration 
cycle, and as a consequence healthy tissue is irradiated. Respiration gating is a method used 
to improve the accuracy of radiation therapy by a means of gating (turning off and on) the 
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radiation beam to synchronize with a particular phase of a patients respiration cycle. For a 
target which is moving due to respiration, this means that it will only be irradiated when it is 
at the same point in the treatment field for each breath. The end of the expiration phase is 
normally chosen because the amount of motion is at its least. This technique will allow the 
reduction in the margins of the ITV, consequently less healthy tissue will be irradiated.  This 
leads to less tissue complications and potentially allows for higher doses to be delivered to 
the PTV for greater tumour control. Firstly a patient will need to be assessed to see if they 
will be a good candidate for gated treatment. A good candidate will have good lung function 
and a breathing pattern which is steady and reproducible. Typically a patient will have their 
CT simulation and in addition to the routine tasks done, they will also have their breathing 
pattern traced. Either from infrared video system monitoring a marker placed on their chest, 
or a bellows system which is a spring wrapped around the chest which expands and 
contracts with each breath.  
 
During the past 10 years, respiratory gating in radiation therapy has become more prevalent, 
especially with the introduction of 4DCT for simulation. Prior to this, breath hold CT scans 
were taken as was the case for (Berson A. M., Emery R. et al. 2004) who treated 108 
patients with this technique and concluded that gating was a practical and achievable 
solution for minimising target motion. The key to successful treatment delivery is for the 
patient to breath at a reproducible manner, both in amplitude and frequency. (Kini V. R., 
Vedam S. S. et al. 2003) used auditory prompts and a monitor for the patient to see their 
breathing trace in real time. These significantly improved the patient ability to maintain a 
consistent amplitude and frequency in their breathing over the patient free breathing with no 
outside assistance. (D'Souza W. D., Nazareth D. P. et al. 2007) used 4DCT to obtain 3D CT 
data sets at 8 different phases of the patients respiration cycle. Gated plans were created and 
compared to a free breathing plan and it was found that there was dose reduction in normal 
tissues including the kidneys for the gated plans. (Mian X., Li Z. et al. 2011) carried out a 
dosimetric analysis on 12 patients with hepatocellular carcinoma, and it was found that 
respiratory gating reduced the ITV margins sparing healthy tissue and allowing doses to be 
escalated especially for tumour movement of greater than 1cm. However (Muirhead R., 
Featherstone C. et al. 2010) compared gated end inspiration and gated end expiration plans 
with non-gated continuous 4DCT plans and found only a limited reduction in toxicity for the 
gated plans. And due to the additional potential errors involved with the delivery of gated 
radiation therapy, they recommended comparative planning (gated and non-gated) to be 
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performed and gated treatment to commence only if a significant clinical benefit is 
confirmed. Additionally (Van der Geld Y. G., Van Triest B. et al. 2008) compared 
conformal radiation therapy (CRT) to intensity modulated radiation therapy (IMRT) and 
respiratory gated radiation therapy (RGRT) plans for pancreatic cancer and found that 
RGRT did not reduce the dose to kidneys or other OAR when compared with the CRT and 
IMRT plans. 
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Chapter 3 – Equipment and Software 
There were six essential pieces of equipment required for this project. Two CT scanners, 
two treatment planning computers, the QUASAR phantom, (Respiratory motion phantom) 
and a linear accelerator (Varian 21iX). All the equipment used in this project is described 
below: 
 
2.1. CT Scanners 
Two CT scanners were used in this project because in the time between the patient study and 
the phantom study the department had superseded the Picker scanner with the Toshiba 
scanner. 
 
2.1.1. Picker PQ6000 
The CT scanner used for the patient study was a fifth generation helical scanner 
manufactured by Phillips Medical Systems. Patients were scanned using the departments 
abdominal protocol where the scanner operated at 130kV and 150 mA with a slice thickness 
of 5mm.  
 
2.1.2. Toshiba Aquilion LB 
The Toshiba Aquilion LB is a seventh generation helical scanner and it was used for the 
phantom study. The Aquilion is a large bore CT with 90cm aperture providing a 70cm field 
of view (FOV) which is ideal for CT simulation for radiation therapy. Some patients may 
require treatment where their arms are held above their heads with the elbows pointing 
outwards, CT simulation would need to reproduce this, thus a larger bore would be needed. 
The respiratory motion phantom was scanned using the departments abdominal protocol 
were the scanner operated at 135kV and 150mA with a slice thickness of 3mm. 
 
2.2. QUASAR Programmable Respiratory Motion Phantom 
QUASAR (Quality Assurance System for Advanced Radiotherapy) by Modus Medical 
Devices is a programmable respiratory motion phantom which can be used to test and 
commission the dosimetric functions of CT simulations, treatment planning computers and 
linear accelerators. Additional motion inserts can also be used to perform quality assurance 
on 4DCT scanners, positron emission tomography (PET) scanners. For the purposes of this 
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project the acrylic film insert was used. The insert is 8cm in diameter and 18cm in length, 
and it can house a piece of film up to 15cm x 6.5cm in size. The insert can be orientated 
vertically or horizontally within the phantom. The translation stage can be manually 
adjusted to allow for oscillations of up to 4cm in amplitude. The programmable drive unit 
can adjust the frequency of oscillation from 4.00 breaths per minute to 60.00 breaths per 
minute. The phantom can also connect via Ethernet cable to a computer where breathing 
waveforms generated by 3
rd
 party equipment can be imported and the software can drive the 
phantom to reproduce the waveform. For this project the phantom was kept under manual 
control adjusting the amplitude and frequency where needed. 
 
2.3. Treatment Planning Systems 
Two treatment planning systems were used in this project because in the time between the 
patient study and the phantom study, the department had upgraded from Theraplan Plus to 
the new Eclipse planning system. 
 
2.3.1. Theraplan Plus 
Theraplan Plus is a treatment planning system developed by Theratronics, now owned by 
Nucletron. CT scans of the patients from the Picker PQ6000 were imported into Theraplan 
Plus and the software was then used to create the patient plan. The plan was copied onto the 
two breath hold data sets, and all three plans were calculated for dose. The software was 
then used to obtain dose-volume histograms. 
 
2.3.2. Eclipse 
Eclipse treatment planning system was designed and developed by Varian Medical Systems 
and was used in the phantom study. CT scans of the phantom from the Toshiba Aquilion LB 
were imported into Eclipse. The software was then used to create a plan on the CT set of the 
respiratory phantom and dose was calculated. Dose profiles of this plan were then generated 
and compared to measurements.  
 
2.4. Linear Accelerator 
The irradiation of the respiratory motion phantom and film was performed by a linear 
accelerator (linac) manufactured by Varian Medical Systems in 2007. The linac was a 
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‘21iX’ model with two photon energies (6 and 18MV) and five electron energies (6, 9, 12, 
16, 20 MeV). The linac is departmentally known as ‘LA3’.  
 
2.5. ImageJ 
ImageJ is image processing software developed by the National Institutes of Health in 
Maryland, USA. The software is in the public domain and written in Java script. For this 
project ImageJ was used to crop the screen captures, then covert them to a binary image, and 
finally used to determine the location of the centre of mass of the kidney outlines.  
 
2.6. Gafchromic Film EBT2 
Gafchromic film is a type of processor-less film developed by International Speciality 
Products Inc. The film self-develops in real time as it is being irradiated. The EBT2 film 
comes in sheets of 8 x 10 inches, which was then cut up to size. The film has a dose 
sensitivity of 1cGy to 40Gy, has an independent energy response and has near tissue 
equivalence.  
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Chapter 4 – Patient Studies 
The purpose of this study was to quantify the magnitude and direction of movement in the 
kidneys of radiation therapy patients between the inspiration and exhalation phases of their 
breathing cycle. To determine these values, CT scans were taken of these patients whilst free 
breathing (FB), breath-hold at normal tidal inspiration (BHIN), and breath-hold at normal 
tidal expiration. (BHEX) As of yet there is no gold standard technique to accurately quantify 
this movement.  
 
4.1. Patient Volunteer Selection 
In order to determine if there is a significant difference between the expiration and 
inspiration scans, an appropriate sample size was chosen using equation 4.1 which is used to 
compare the means of two independent groups.  
( ) 2
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Where Zα is the two-tailed critical Z ratio, Zβ is the lower one-tailed critical Z ratio. (Rosner 
B. 2006) Zα and Zβ were set at 1.96 and -1.28 which corresponds to a level of confidence α 
= 0.05 and β = 0.1.  This gives a 90% probability of detecting a significant difference. The 
standard deviation s of a sample of 54 was taken from (Van Sorsen de Koste J. R., Senan S. 
et al. 2006) and found to be 5mm for the left kidney. For the purposes of this study, the 
sample size must be large enough to detect a 7mm difference between the two means µ1 and 
µ2.  Substituting these values into equation 4.1: 
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Therefore a sample size of 11 patients was needed for this research. The sample size was 
increased to 16 to ensure there were enough remaining should some patients needed to be 
removed from the study. 
 
Patients were selected for potential recruitment for this study at the discretion of their 
treating Radiation Oncologist. The main criteria was if the Radiation Oncologist believed 
they had adequate lung function to maintain the breath holds for the CT scans, and that their 
planning CT scan (free breathing) would cover their kidneys, to avoid unnecessary 
irradiation. Before recruitment could start ethical approval was required from both QUT and 
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Barwon Health. The use of ionising radiation on humans required ethical clearance from the 
Department of Human Services as well. Subjects were given a Patient Information Package 
in the presence of the researcher and clinical supervisor. Volunteers then signed the Consent 
form. These forms can be found in Appendix A. 
 
The 16 subjects recruited for this study ranged in age from 32-80.  The subjects included 11 
males and 5 females. All subjects were patients due to commence radiation therapy at the 
Andrew Love Cancer Centre. As the planning CT scan covered their kidneys, the treatment 
sites were all in the abdominal region. There were a variety of diagnosis, with seminoma 
and gastric adenocarcinoma being most common. Table 4.1 contains information recorded 
for each of the subjects. 
 
Table 4-1 Demographics of patient volunteers in the study. 
Patient Sex Age Dose (Gray) Fractions Energy (MV) Intent Diagnosis 
1 M 50 30 20 6/18 Radical 
Large B cell non-Hodgkin’s 
lymphoma 
2 M 47 25 20 18 Radical Seminoma 
3 M 72 45 25 6/18 Radical Gastric adenocarcinoma 
4 M 48 45 25 6/18 Palliative Pancreatic carcinoma 
5 M 44 25 20 18 Radical Seminoma 
6 M 66 35 12 6 Palliative Gastric adenocarcinoma 
7 M 67 35 15 6/18 Palliative Gastric adenocarcinoma 
8 F 80 50.4 28 18 Radical 
Endometrioid 
adenocarcinoma 
9 M 36 25 15 18 Radical Seminoma 
10 M 78 36 20 6/18 Radical 
Large B cell non-Hodgkin’s 
lymphoma 
11 M 32 25 15 18 Radical Seminoma 
12 M 39 25 15 6 Radical Seminoma 
13 F 75 45 25 6/18 Radical Gastric adenocarcinoma 
14 F 33 45 25 18 Radical SCC cervix 
15 F 56 35 15 6 Palliative Gastric adenocarcinoma 
16 F 73 50.4 28 6 Palliative Gastric adenocarcinoma 
  
4.2. Method 
The experimental procedure was the same for all of the subjects. Once the subject had read 
the information package and signed the consent forms, subjects received their planning CT 
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scan as per the normal standard practice. Slice thickness was set at the ALCC protocol for 
abdominal sites at 5mm. Once it had finished the subject remained still whilst the CT 
scanner was reset to cover the range of the kidneys. The subjects were then coached through 
a speaker to inhale and exhale and then asked to hold at end of expiration. The CT scan was 
started again by a trained operator. The subject was then instructed to breath normally 
immediately after the scan had finished. The procedure was then repeated for the end 
inspiration study. The time required to do the two extra scans was less than 5 minutes.  
 
Subject 1 was removed from the study because they were unable to maintain the breath 
holds for the BHEX and BHIN scans. Subject 8 was removed due to the fact that their 
planning scan was taken with the patient lying prone on a belly board. The purpose of a 
bellyboard is to allow the patients abdomen and small intestine to fall into a void in the 
couch top moving them away from the treatment field. Considering all the other subjects up 
til that point were scanned in the supine position, the decision to remove this subject was 
made, as it was unknown what effect lying prone with a bellyboard would have on kidney 
motion 
 
The three sets of CT scans were then exported to the Theraplan Plus treatment planning 
system. An experienced Radiation Therapist then designed a plan to treat the para-aortics 
with opposed lateral fields on the free breathing scan. Para-aortics are normally treated with 
anterior and posterior fields, and kidney movement or dose would not be an issue as the 
field would be in-between both kidneys. However the spinal cord will be in the middle of 
the field, and if the radiation oncologist perceives this to be a problem, then lateral fields can 
be applied to miss the spinal cord. To ensure consistency, the same landmarks on each 
subject were used to construct the fields. The top of the spinous process of vertebrae L1 was 
located and field made 8cm wide at this point (4cm either side of the spinous process). The 
field was then extended in the supine direction to the superior aspect of vertebrae T10, and 
inferiorly to the inferior aspect of vertebrae L3. The isocentre was then shifted anteriorly so 
the posterior field edges included 1cm of the most anterior kidney. Dose was then calculated 
on the plan and a prescription dose of 45Gy in 25 fractions applied. Because all three CT 
scans were taken consecutively it was assumed there was no patient setup variation between 
the scans. The fields from the free breathing scan were copied over to the breath hold scans, 
and dose was then calculated maintaining the same monitor units as the free breathing plan. 
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Dose volume histograms (DVH) were calculated for the left and right kidneys for all three 
plans, and from these the percentage volume of kidney receiving 10 Gy was determined. 
 
To measure the magnitude and direction of motion of the kidneys, screenshots of the 
anterior beams eye view (BEV) were taken for the three plans. The screenshots were then 
opened with the ImageJ software. The image was cropped to contain just the BEV, and then 
converted to binary. The software then calculated the co-ordinate of the centre of mass of 
the left and right kidneys outlines, and a 4x4 field located at isocentre. (Figure 4.4) This 
field was included as the isocentre is the same point for all three scans. The 4x4 field size 
was used to convert distances from number of pixels to millimetres. Using the location of 
the centre of mass of the 4x4 field as a reference point, the distance to the centre of mass of 
the kidneys was calculated. The anterior BEV provided information about the magnitude of 
motion in the superior-inferior direction and lateral-medial direction. The same procedure 
was then used on the lateral BEV in order to determine the magnitude of motion in the 
anterior-posterior direction.  
 
4.3. Results and Analysis 
Both left and right kidneys were contoured on the three CT sets by an experienced radiation 
therapist. After being contoured, Theraplan Plus calculated their volumes.  The calculated 
volumes are presented in Table 4.2. The difference between expiration and inspiration 
kidney volumes is shown in Table 4.3. 
Table 4-2 Kidney volumes determined from Theraplan Plus of the three CT sets. 
Patient Free Breathing  (FB) 
Volume (cm
3
) 
Expiration (BHEX) 
Volume (cm
3
) 
Inspiration (BHIN) 
Volume (cm
3
) 
 Left Right Left Right Left Right 
2 212.75 170.02 222.50 163.97 214.11 166.55 
3 208.39 215.15 181.09 195.73 188.98 201.47 
4 185.84 195.16 190.01 191.12 187.09 194.92 
5 244.51 220.04 244.74 229.23 242.52 225.14 
6 255.49 142.98 263.11 130.21 253.96 130.21 
7 216.35 202.10 207.82 206.56 190.08 201.20 
9 188.85 206.47 187.34 208.97 191.62 198.86 
10 136.07 138.86 132.45 148.34 136.86 131.27 
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11 153.27 142.13 158.34 145.22 161.01 146.00 
12 182.80 166.50 184.48 170.83 191.59 162.58 
13 111.35 96.36 109.18 93.95 111.44 99.19 
14 162.36 158.02 170.21 160.82 164.30 155.44 
15 153.10 154.48 174.26 154.73 172.09 151.21 
16 97.34 90.52 93.64 90.43 94.28 119.78 
 
Table 4-3 Change in kidney volume between the BHEX and BHIN CT sets. 
Patient ∆V  Left 
(cm
3
) 
∆V  Right 
(cm
3
) 
Patient ∆V  Left 
(cm
3
) 
∆V  Right 
(cm
3
) 
2 8.39 -2.58 10 -4.41 17.1 
3 -7.89 -5.74 11 -2.67 -0.78 
4 2.92 -3.8 12 -7.11 8.25 
5 2.22 4.09 13 -2.26 -5.24 
6 9.15 0.00 14 5.91 5.38 
7 17.7 5.36 15 2.17 3.52 
9 -4.28 10.1 16 -0.64 -29.4 
 
After the CT sets were contoured and had their lateral para-aortic fields added, dose was 
calculated maintaining the same monitor units. (Figure 4.1 and 4.2)  Dose volume 
histograms for the left and right kidneys were calculated (Figure 4.3) on Theraplan Plus and 
the percentage volume of kidney receiving 10 Gy was found, the results are in Table 4.4. 
Figure 4-1 Lateral BEV (left) of BHEX scan showing left kidney on the edge of the treatment field. Dose 
calculation shown on the right. 
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Figure 4-2 Lateral BEV (left) of BHIN scan showing both kidneys have moved anteriorly inside the 
treatment field . Dose calculation shown on the right. 
 
Figure 4-3 DVH for kidneys at BHEX (left) and BHIN (right) showing the increase in dose both kidneys 
receive during Inspiration 
 
Table 4-4 Percentage volume of kidney receiving 10 Gy for free breathing and breath hold scans 
Patient Free Breathing  (FB)       
% Volume at 10 Gy 
Expiration (BHEX)      
% Volume at 10 Gy 
Inspiration (BHIN)      
% Volume at 10 Gy 
 Left Right Left Right Left Right 
2 1.29 12.95 1.13 35.05 1.11 41.83 
3 8.02 0.00 5.35 0.00 32.03 6.07 
4 8.21 10.53 6.12 6.09 7.76 18.28 
5 7.62 11.37 9.81 12.49 8.15 8.83 
6 3.62 0.00 2.19 0.00 2.66 0.00 
7 7.34 0.81 4.64 1.27 42.90 34.75 
9 1.33 4.78 0.07 2.63 1.70 4.59 
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10 7.81 0.18 19.93 2.41 34.01 16.33 
11 3.18 16.45 1.82 12.31 11.18 26.98 
12 7.64 17.73 10.38 21.93 12.4 22.56 
13 0.90 9.98 0.11 2.67 27.77 24.40 
14 1.93 11.79 0.96 14.71 5.63 17.06 
15 4.98 16.34 21.32 32.26 19.84 25.89 
16 8.35 9.66 16.42 14.38 32.09 38.13 
 
Table 4-5 Change in kidney dose between plan on BHEX and BHIN. Values below are percentage 
difference of kidney volume receiving 10 Gray. 
 
The magnitude and direction of kidney motion was calculated from the BEV images of the 
BHIN and BHEX scans. (Figure 4.4) Using ImageJ, the centre of mass was calculated for 
the left and right kidney contours of the BEV images. The results were given as an x-pixel, 
y-pixel co-ordinate which was dependant on how the image was cropped from the original 
screenshot. There was no common point of reference between the BHEX and BHIN images. 
A 4x4 field was included for this reason, it’s centre of mass calculated by ImageJ would be 
the isocentre, a point that is common between the BHEX and BHIN plans. The 4cm edge of 
the field was used to convert distance in number of pixels to distance in centimetres.  
Patient % Change  (L) 
Volume at 10 Gy 
% Change  (R) 
Volume at 10 Gy 
Patient % Change  (L) 
Volume at 10 Gy 
% Change  (R) 
Volume at 10 Gy 
2 -0.02 6.78 10 14.08 13.92 
3 26.68 6.07 11 9.36 14.67 
4 1.64 12.19 12 2.02 0.63 
5 -1.66 -3.66 13 27.66 21.73 
6 0.47 0.00 14 4.67 2.35 
7 38.26 33.48 15 -1.48 -6.37 
9 1.63 1.96 16 15.67 23.75 
Average 9.93 9.11 
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Figure 4-4 Anterior-Posterior BEV, after ImageJ editing, showing the change in position of the kidneys 
between BHEX (left) and BHIN (right) relative to the 4x4 field positioned at isocentre.  
 
 
Knowing the co-ordinates of the centre of mass for all three contours, the distance in the x 
(lateral-medial) plane and y (superior-inferior) plane between each kidney and the isocentre 
can be calculated. Because the isocentre is a common point in space between the BHEX and 
BHIN images, the distance the kidney moves between exhalation and inspiration is the 
difference between the two. The same method was used on the lateral BEV in order to 
determine movement in the anterior-posterior plane. Equation 4.3 is used to determine the 
distance the kidney moves in centimetres between exhalation and inspiration in the x 
(lateral-medial) plane. 
 
Distance (x) = [CMx(Kidney-BHEX) – CMx(4x4-BHEX)] – [CMx(Kidney-BHIN) – CMx(4x4-BHIN)]   (4.3) 
 
Table 4-6 Distance of kidney motion between BHEX and BHIN for the three planes 
Patient Sup/Inf Distance (cm) Med/Lat Distance (cm) Ant/Post Distance (cm) 
Lt Kidney Rt Kidney Lt Kidney Rt Kidney Lt Kidney Rt Kidney 
2 0.80 1.01 0.46 0.17 -0.07 -0.50 
3 1.84 1.33 0.01 0.03 -1.41 -1.06 
4 3.50 3.97 0.15 -0.14 -0.14 -0.57 
5 0.40 0.22 0.00 -0.05 -0.06 -0.19 
6 0.51 1.87 0.11 0.02 -0.45 -0.77 
7 4.64 4.37 -0.41 0.08 -2.13 -1.64 
9 0.69 0.71 0.10 -0.02 -0.21 -0.15 
10 2.38 2.52 0.60 0.17 -0.57 -1.13 
11 1.48 1.38 0.43 0.08 -0.49 -0.6 
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12 2.55 1.36 0.32 -0.21 -0.51 -0.48 
13 3.97 2.50 0.52 0.08 -1.6 -1.06 
14 0.97 0.55 0.23 -0.07 -0.25 -0.18 
15 0.86 0.56 -0.09 -0.14 -0.08 -0.22 
16 3.72 3.08 0.36 -0.78 -0.55 -0.24 
Average 2.02 1.82 0.20 -0.06 -0.61 -0.63 
Std Dev 1.44 1.30 0.27 0.24 0.64 0.45 
 
Figure 4-5 Distance of  superior/inferior kidney motion from BHEX to BHIN.  (Left kidney, Blue. Right 
kidney, Red)  Average kidney displacement 2.0cm (Left) and 1.8cm (right) in the inferior direction. 
 
Figure 4-6 Distance of  anterior/posterior kidney motion from BHEX to BHIN.  (Left kidney, Blue. 
Right kidney, Red)  Average kidney displacement 0.6cm for both in the anterior direction. 
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Figure 4-7 Distance of  lateral/medial kidney motion from BHEX to BHIN.  (Left kidney, Blue. Right 
kidney, Red)  Average kidney displacement 0.2cm (Left) and 0.1cm (right) in the lateral direction. 
 
 
In table 4.6 a positive value represents a movement towards the patient’s inferior, posterior 
and their left from exhalation to inspiration. 
 
4.4. Discussion 
A method for determining the direction and magnitude of kidney motion has been presented 
and the dosimetric implications of the motion have been calculated. Using breath hold CT 
scans, the centre of mass of the left and right kidneys was determined from the BEV and the 
distance between the expiration and inspiration scan was found. A standard radiation 
therapy treatment plan was applied to both scans and the dosimetric difference was found.  
 
The largest movement was found in the superior-inferior plane, which agrees with previous 
studies. However this plane is also the one with the largest error, the CT slice thickness was 
set at the department protocol for abdominal scans at 5mm. This was maintained for the 
subsequent breath hold scans. The resolution and consequently uncertainty in that plane is 
5mm also. It should also be noted that the measurements for motion between inspiration and 
expiration do not truly represent a 3D displacement of the kidney, but rather a 2D 
displacement of the centre of mass as deducted from the 2D contour of the BEV. The kidney 
is symmetrical through the coronal plane, therefore the 2D centre of mass acquired from an 
anterior-posterior BEV would be accurate. The lateral BEV (required to determine 
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movement in the anterior-posterior direction of the 2D centre of mass) would be less 
accurate as the kidney is not symmetrical through the sagittal plane.  
 
The volumes obtained from the free breathing scans can not be used for any analysis due to 
the presence of geometric uncertainties. All patients were scanned in a head first supine 
position, and the scan direction was superior to inferior. The kidneys were imaged at an 
unknown point during the respiration cycle, meaning the kidney could have been moving 
inferiorly, superiorly or both while being scanned. For example if the kidney is moving 
superiorly while being scanned, portions of kidney volume will miss being sampled, the 
resultant kidney volume will be smaller. If the kidney is moving inferiorly while being 
scanned, portions of the kidney volume will be resampled, the resultant volume will be 
larger. Consequently the kidney volumes for the FB scans will over or underestimate of the 
true volume. If multiple breaths are taken whilst the kidney is being imaged (See Figure 4.5) 
the movement during the scan is responsible for the sawtooth effect seen in the free 
breathing BEV screenshots.  
Figure 4-8 Motion during CT acquisition can lead to tissue volumes being missed or resampled leading 
to erroneous free breathing BEV as seen on the right . 
  
The ideal situation during the breath hold scan is for the kidney to be stationary, and 
therefore should have the same volume and BHEX and BHIN. Table 4.3 shows the 
difference in kidney volume between the two scans. Ideally there should be none and 
reasons for these differences can include the 5mm scan slice thickness, the kidney could 
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deform in shape differently (compressed or stretched) at the ends of the respiration cycle, or 
from slightly inconsistent contouring of the kidney. Table 4.4 and 4.5 show the increase in 
kidney dose from expiration to inspiration. The average increase in percentage volume of 
the kidney receiving 10 Gy, from expiration to inspiration, was 10% and 9% for the left and 
right kidneys. The anterior motion of the kidney during inspiration moves it closer to and 
into the treatment field.  Consequently a higher volume of the kidney receives a higher dose, 
this can be seen in Figure 4.1 and Figure 4.2. The resulting increase in dose is easily seen in 
the side by side dose-volume histograms in Figure 4.3.  
 
Table 4.6 shows kidney motion to be largest in the superior-inferior plane, followed by the 
anterior-posterior plane, then lateral-medial plane. As reported by (Schwartz L. H., Richuad 
J. et al. 1994), who found superior-inferior displacements of up to 4cm forced ventilation 
breath holds, it appears this study had several patients (4, 7, 13 and 16) who have kidney 
displacements more representative of being under forced conditions, even though they were 
instructed and coached to hold their breath under normal tidal respiration.  
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Chapter 5 – Respiratory Motion Phantom Studies 
The purpose of this study was to use the information obtained from the previous chapter 
regarding magnitude of motion and apply it to a respiratory motion phantom. Film was 
irradiated whilst undergoing oscillatory motion of varying magnitudes and the dose from the 
film was then compared to dose calculated on the treatment planning system. 
 
5.1. Method - Eclipse 
The QUASAR respiratory motion phantom was scanned with the Toshiba Aquilion LB 
using the departments abdominal protocol of 135kV, 150mA and 3mm slices. The phantom 
was scanned with the film insert in place with the translation stage set up at the zero mark. 
The phantom was scanned whilst static, and then exported to the Eclipse treatment planning 
system.  
 
The static CT image set was used for all dosimetric calculations. Within Eclipse a single 
lateral field (Gantry at 90°) with a field size of 6x6 cm was applied. The isocentre was 
placed in the middle of the phantom which gave a source to surface distance (SSD) of 85cm. 
A couch longitudinal shift of 3cm inferior was applied so the field penumbra was in the 
middle of the phantom and film. A reference point was placed in the centre of the field at a 
depth of 5.5cm, which is the depth to the film plane. The field setup is shown in Figure 5.1. 
Figure 5-1 Eclipse screenshot showing the setup of the single lateral field on the QUASAR phantom. 
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The dose prescription for this plan was set at 2 Gy at the reference point in a single fraction. 
Dose was then calculation by Eclipse using the Analytical Anisotropic Algorithm (AAA) 
which yielded the dose distribution and monitor units needed, 189, to deliver the 2 Gy to the 
reference point. The results of the dose calculation can be seen in Figure 5.2 below. 
Figure 5-2 Eclipse screenshot showing the dose calculation. The plan was normalised to deliver 2Gy to 
the depth of the film plane.  
 
Using the line profile tool, a dose profile was obtained through the plane of the film, seen in 
Figure 5.3. The data for this profile was exported to Excel and used to compare against the 
profiles of the irradiated film. 
Figure 5-3 Dose profile of film plane calculated on Eclipse 
 
Film plane 
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5.2. Method - Film Irradiation 
All irradiation measurements were carried out in linear accelerator bunker LA3. Firstly the 
linear accelerators output for 6MV was measured. This was carried out following the 
department’s fortnightly QA procedure with a farmer type ion chamber and a Perspex 
phantom.  
 
The Gafchromic EBT2 film was then calibrated under reference conditions set up using 
solid water slabs. The film was cut up into twenty 5 x 5cm pieces. A piece film was placed 
at depth of dose maximum (dmax) for the 6MV beam of 1.5cm. Source to surface distance 
(SSD) was set to 100cm and field size set to 10 x 10cm. One piece of film was kept un-
irradiated, the 19 other pieces were exposed to increasing amounts of known radiation up to 
2.09 Gy (See Figure 5.4) 
Figure 5-4 Calibration Films.  
 
The film was scanned using an Epsom Expression 10000XL flatbed scanner. A cardboard 
template was used to elevate the film above the glass scan top which is needed to negate the 
presence of Newton’s rings artefacts. A 1x1cm region of interest at the centre of each film 
was selected and the average pixel value found. From this an output corrected dose to pixel 
value calibration curve was obtained. (Figure 5.7) 
 
The QUASAR respiratory motion phantom was then set up on the treatment couch (Figure 
5.5) with the film insert on the translation stage. A 4 x 15cm strip of Gafchromic film was 
placed inside the film insert. The translation stage was set to the zero position with no 
oscillation applied. The 2 Gy was then delivered to the depth of the film in the phantom, this 
required 189 monitor units. The film was removed and replaced with another piece. The 
translation stage was then set to oscillate with 1cm amplitude at a frequency of 15 breaths 
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per minute. The average breathing rate for an adult is 12-18 bpm. (Sherwood L. 2006) The 
same dose of 2 Gy was then delivered. The procedure was then repeated for 2, 3 and 4cm 
amplitude oscillations.  
Figure 5-5 QUASAR phantom in treatment position with film insert set up prior to film irradiation 
 
Figure 5-6 Phantom motion films.  No motion (top) to 4cm amplitude (bottom) 
 
The films (Figure 5.6) were then scanned using the same technique as the calibration films, 
and line profiles were generated and compared to the profile from Eclipse. 
Film Insert Translation Stage 
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5.3. Results and Analysis 
Prior to film irradiation the linear accelerator output was measured and found to be 1.0094 
cGy / MU. This correction was then applied to the dose delivered to the calibration films. 
Figure 5.7 shows the plot of output corrected dose versus pixel value. 
Figure 5-7 Film Calibration plot and line of best fit 
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A forth degree polynomial was used to find the line of best fit for the above plot giving the 
following equation. The correlation co-efficient was 0.9995. 
 
y = -1.69e
-16
x
4
 + 2.39e
-11
x
3
 – 0.96e
-6
x
2
 – 0.0052x + 726.27        (5.1) 
 
Using equation 5.1, line profiles of the respiratory motion films could now be converted to  
dose and compared with the calculation of the Eclipse planning system as shown in Figure 
5.8. 
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Figure 5-8 Dose profiles from respiratory motion phantom films and Eclipse. 
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A radiation field’s penumbra is caused by three elements. The source of the radiation being 
a finite size, radiation being scattered within the phantom, and transmission of radiation 
through the shielding jaws of the linear accelerator. (Khan F. M. 2010) The width of the 
penumbra is given by the distance between the 80% and 20% points on the dose profile. 
This gives a measure of how sharp or broad a penumbra is and are recorded in table 5.1. The 
broader a penumbra is, the more the radiation underdoses inside the field, and overdoses 
outside. This can be seen in table 5.2. The noise in the film profiles is evident, especially 
where uniform dose was delivered at 200cGy. This can be attributed to the inhomogeneities 
in the pixel values. (Hartmann B., Martisikova M. et al. 2010) measured this for EBT2 film 
and determined it to be ±3.7%. This uncertainty has been applied to the values for the film 
scans in tables 5.1 and 5.2.  
Table 5-1 Dose profile penumbra. Distance between the 80% and 20% values. 
Profile type 80% - 20% distance (mm) 
Eclipse 3.2 
Static 2.8 ± 0.2 
1cm amplitude 8.6 ± 0.3 
2cm amplitude 16.7 ± 0.6 
3cm amplitude 24.5 ± 0.9 
4cm amplitude 34.0 ± 1.2 
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 Table 5-2 Underdosing and Overdosing seen 1cm either side of field 
Profile type % Dose 1cm inside field % Dose 1cm outside field 
Eclipse 98.9 8.9 
Static* 100.2 5.1 
1cm amplitude* 98.9 7.9 
2cm amplitude* 92.3 16.9 
3cm amplitude* 80.0 36.7 
4cm amplitude* 74.7 43.2 
* Uncertainty: 3.7% 
5.4. Discussion 
The range of motions found from the patient studies were applied to a respiratory motion 
phantom. The dosimetric effects of these motions were studied using film dosimetry and 
compared to that of the treatment planning system. 
 
The treatment planning was performed on the scan of the respiratory motion phantom whilst 
it was static positioned at the zero mark.  As the film insert was homogenous, any motion 
within the phantom would not be able to be seen from the CT data.  
 
All five respiratory motion films had less 5% variation in the open field where a uniform 
dose was delivered. This is due to noise caused my non-uniformities in the activation layer 
of the film, and noise in the flatbed scanner electronics. The static film profile has a slightly 
sharper penumbra compared to the Eclipse profile. This is because Eclipse treatment 
planning system was configured with dose profiles that were measured an ion chamber with 
a measuring volume of 0.10 cm
3
. When these ion chambers measure regions with a high 
dose gradient (as in the penumbra) and the dose is higher on one side of the chamber than 
the other, the resulting dose reading is averaged. The film was scanned at a resolution of 
72dpi which is 28 points of measurement every centimetre. The higher resolution of film 
dosimetry gives a sharper penumbra.  
 
As expected the greater the magnitude of oscillation, the greater the penumbra. This 
consequently leads to significant under-dosing within the treatment field as seen in table 5.2. 
With the phantom set up at 85cm SSD and the isocentre set at the middle of the phantom, 
the field size at the film depth was 5.45cm. Therefore the field edge was at 2.725cm, and 
dose readings were taken at 1.725cm and 3.725cm. The 4cm amplitude oscillation showed 
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an approximate 25% reduction in dose 1cm inside the treatment area, and an increase in 
dose from 5.1% to 43.2% 1cm outside the treatment area. 
 
In figure 5.8 the 4cm amplitude oscillation dose profile there is a sharp drop of dose inside 
the field and a ‘bulge’ in the dose outside. This is due to uneven irradiation of the film. The 
linear accelerator delivers dose at 600 mu/min (this is the departmental default dose rate for 
clinical radiation therapy) and with only 189 mu to deliver the treatment the beam on time 
was only 18.9 seconds. The respiratory phantom was set at 15 breaths per minute, 1 breath 
every 4 seconds therefore the film went though 4.7 oscillations while receiving dose. 
Because of the small number of non-unity oscillations, some parts of the film received a 
little more dose than others. In hindsight, the dose rate of the linear accelerator should have 
lowered, allowing for a greater number of oscillations and less dose per oscillation. This 
would have made the dose drop off in the penumbra more uniform.  
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Chapter 6 – Conclusions and Recommendations 
6.1. Conclusions 
The primary aim of this research was to quantify the magnitude and direction of kidney 
motion due to respiration by means of CT imaging during breath holds. The minor aims 
included determining the dosimetric impact of the motion from; information from the dose-
volume histograms, and comparing film dosimetry measurements using a respiratory motion 
phantom with treatment planning system data. 
 
Much research has been done in the area of organ motion due to respiration, and its potential 
effects on the quality of radiation therapy treatment. Quantifying this motion requires the 
patient to be imaged, and many different types of imaging modalities have been used. Using 
computed tomography scans for radiation therapy patients is a logical choice as patients will 
be required to undergo a CT scan for treatment planning purposes anyway, breath hold scans 
can be taken in the same session as the planning scan adding only a few more minutes of the 
patients time, and the dose concerns from the additional CT scans are negligible compared 
to the dose the patients will receive from the radiation therapy. 
 
A group of 16 radiation therapy patients were recruited for this study, of which 14 were used 
in the analysis. These 14 had CT scans taken for their radiation therapy planning purpose 
and in addition breath hold scans of the kidneys at BHEX and BHIN. Beam arrangements 
simulating treating the para-aortics with lateral fields to 45 Gy were generated on the free 
breathing scan on Theraplan Plus planning system. These fields were copied over and 
calculated on the breath holds scans. It was found that the percentage volume of kidney 
receiving 10 Gy increased on average by 10% from expiration to inspiration. This is caused 
by the kidney moving anteriorly into the treatment field during this phase of respiration.  
 
The greatest uncertainty lies in where the kidney was positioned during the free breathing 
scan. If the kidney was imaged towards the end inspiration phase the kidneys will be close 
to their maximum anterior displacement. Therefore there will be little difference in kidney 
dose between that plan and the BHIN plan. Conversely a kidney imaged towards the end 
inspiration phase will be close to its maximum posterior displacement. Therefore when the 
fields are copied over and calculated on the BHIN plan a larger portion of the kidney 
volume will be irradiated. Uncertainty in the kidneys position and an erroneous volume can 
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lead to misleading results in dose-volume histograms required for plan evaluation. Also the 
free breathing fields were positioned with the posterior edge to be irradiating no more than 
1cm of the most anterior kidney. This followed departmental procedure for lateral para-
aortic fields, however this leads to a large variation in V10 (percentage volume of kidney 
receiving 10 Gy) for the free breathing set. (3.62% to 17.73%) This is because the procedure 
does not take into consideration that each patients kidney is a different volume, or how the 
kidney is orientated. A tilted kidney would present less volume to be irradiated than a 
kidney that was more square to the field edge. 
 
The magnitude of motion was determined from measuring the change in position of the 
kidney on the BEV from the two breath hold scans. It was found that from expiration to 
inspiration the kidneys moved inferiorly (Left 2.02±1.44cm, Right 1.82±1.30cm) anteriorly 
(Left 0.61±0.64cm, Right 0.63±0.45cm) and laterally (Left 0.20±0.27cm, Right 
0.06±0.24cm)  
 
The QUASAR phantom was used to record the dosimetric effects of respiratory motion on 
radiation therapy. Gafchromic film was irradiated with the phantom oscillation set at static, 
1, 2, 3 and 4cm amplitude. From the patient study it was found that the maximum 
displacement in the superior/inferior plane for both kidneys was 4.6cm, this could not be 
reproduced as the respiratory motion phantom has a maximum amplitude of 4cm. The films 
were scanned and dose profiles extracted and compared with the dose profile calculated 
from the Eclipse treatment planning system. It was found the increase in amplitude of 
oscillation changed the dose profile by broadening the penumbra which in turn would lead 
to an underdose inside the treatment field, and overdose outside. The penumbras for the 
planning system and the static film were found to be 3.2mm and 2.8mm respectively. The 
0.4mm difference between planning system and measurement is well within the tolerance of 
2mm (Van Dyk J., Rosenwald J-C. et al. 2004) for square fields in homogeneous phantoms 
for doses in penumbral regions. The same can not be said for the increasing amplitude 
oscillations where the penumbras were measured to be 8.6, 16.7, 24.5, and 34.0mm 
respectively.  
 
This research has confirmed that there is significant and varied range of movement of the 
kidneys during respiration. And that the effects of this motion have implications in treatment 
planning evaluation from motion during the CT scan. This brings into question the accuracy 
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of the 3D CT model created during free breathing. Additionally respiration causing motion 
during radiation therapy delivery has been shown to cause underdosing the treatment 
volume and overdosing healthy tissue.  
 
6.2. Recommendations 
Recommendations that can be made based on this research include: 
Caution to be taken when evaluating treatment plans where organ motion is a concern. 
Organ volumes and subsequent doses those organs are calculated to receive can be 
erroneous. 4DCT scanning is the ideal solution for this problem as CT sets are created at 
multiple phases through the respiration cycle. Quicker scanning is another option, the faster 
the scan the less time an organ has to move. This can be achieved by increasing the pitch 
(the ratio of couch movement to source rotation) of a helical scanner, and also by using 
modern seventh generation CT scanners with their larger multiple detector arrays (MDA) 
ability to capture a wider volume of data in a single rotation. Breath hold techniques can be 
employed to get accurate organ volumes. 
 
There was no control over how much air a patient expired or inspired before the breath hold 
scan. Using a spirometry apparatus would have allowed a measurement of the volume of air 
a patient respires under normal conditions, and a reproducible point in the respiration cycle 
to be used for the breath holds. 
 
The largest motion of the kidneys was recorded in the superior/inferior plane, however this 
plane also had the largest margin of error due to the 5mm slices. This error could be reduced 
by scanning with a smaller slice thickness now common in modern scanners which can now 
image in sub-millimetre slices. This was not performed for this research as it was decided to 
perform the breath hold scans using the same abdominal CT protocol as the planning scan. 
 
Further areas of study/research based on this project include: 
Performing a similar study to measure kidney motion using a 4DCT and to calculate the 
dosimetric impact using a 4D planning system. 
 
Patient specific quality assurance involving having a 4DCT where their breathing waveform 
is recorded. This waveform can be imported into the software controlling the QUASAR 
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phantom, which can be treated with the actual plan created for the patient. The dosimetric 
impact of the motion can be measured with film or ion chambers, and analysed before the 
patient has received any radiation. With the information gained from the patient specific 
quality assurance the radiation oncologists can adjust the plan if necessary.  
 45
Appendix A-1  Ethical Clearance QUT 
 
 46
Appendix A-2  Ethical Clearance Barwon Health 
 
 
 47
 
 
 
 
 
 48
Appendix A-3  Ethical Clearance Department of 
Human Services 
 
 
 49
Appendix A-4  Patient Information Form 
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Dr Rod Lynch +61 [0]3 5226 7856 
Dr Ian Porter +61 [0]3 5226 7419 
  
QUT School of Physical and Chemical Sciences 
Guy Jenetsky +61 [0]3 52267869 
Dr Stephen Hughes +61 [0]7 38642327 
 
 
Andrew Love Cancer Centre 
 
Patient Information and Consent Form 
 
The Effect of Organ Motion on Radiotherapy Plans. 
A signed copy of this form must be provided to the patient prior to study entry. 
This study is the basis of a Masters (by Research) degree at Queensland University of 
Technology (QUT) and will be performed by Guy Jenetsky (B.App.Sci) (Researcher) under 
the guidance of an academic staff member Dr Stephen Hughes of QUT and Dr Rod Lynch 
of Barwon Health. 
 
INTRODUCTION 
 
You are being asked to take part in a clinical research study. This study is for patients who 
are currently undergoing (or about to start) radiotherapy. 
This form is to provide you with enough information so you can understand the possible 
risks of participating in this trial, so that you can decide whether or not you wish to be part 
of this study. 
The Barwon Health Research and Ethics Advisory Committee has approved this study, 
which is the committee to insure that, the rights of human subjects are protected at Barwon 
Health.  
We recommend you also notify your GP if you decide to participate in the study. 
 
OBJECTIVES OF THE STUDY  
 
This is a clinical study for patients undergoing (or about to start) radiotherapy. The aim of 
this study is to determine the effect of breathing movements on the amount of radiation 
absorbed by the tumour and surrounding healthy tissue during radiotherapy. With this 
knowledge a better understanding of how organs (such as lungs, liver, kidneys) move due to 
the effect of breathing will be obtained, which may lead to improved radiotherapy 
treatments in the future. 
 
RATIONALE OF THE STUDY 
 
It is well known that abdominal and thoracic organs undergo a periodic movement as a 
result of the respiration cycle. This motion can effect the dose distribution to the tumour. 
Taking two planning CT scans of maximal and minimal tidal respiration can determine the 
range of motion of those organs around the target site.  
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TEST PROCEDURES 
 
As a participant you should be currently undergoing (or about to start) radiotherapy in the 
abdominal or thoracic region. Normally you would be required to undergo a CT scan for 
treatment planning purposes. For this study you will be required to undergo two extra 
planning CT scans; one where you hold your breath at the top of your respiration cycle, the 
other at the bottom of your respiration cycle. Before the scans are taken, you will be 
required to perform two practice breath holds for 10 seconds. Upon completion of this we 
will continue with the test scans with your consent. You will be required to hold your breath 
for 10 seconds every 20 seconds. You will be told when to hold your breath and (10 seconds 
later) when to start. The duration for all three of these scans (planning scan, and the two 
required for this study) will be 5-6 minutes, and is the only involvement required by you for 
this study. 
 
RISKS AND DISCOMFORTS 
 
The only discomfort you may feel is from holding your breath for 10 seconds. Apart from 
that the scans for this study are identical to the scans taken for treatment planning purposes. 
There is a risk of the ionising radiation from the two scans that you would not normally 
receive. However, as a patient who is about to undergo radiotherapy the risk from the extra 
dose from these scans needed for this study is negligible, as the dose caused from the extra 
scans will be several thousand times less than the dose from the radiotherapy.  
The amount of radiation received by you for the two additional CT scans will be between 
20-32 milli-Sieverts. This dose will be about the amount you, and everyone else in 
Australia, will receive from 13 – 21 years from natural background radiation. This 
background radiation comes from the sun (cosmic rays), traces of radioactive material in the 
soil and our bodies, and in the air we breathe. Everyone is exposed to this radiation. 
There may be additional risks that are unforeseeable at this time, you will be informed of 
any new and significant information should it arise. 
 
USE OF INFORMATION FROM THE STUDY 
 
Although the information acquired from this study will be of no direct benefit to yourself, it 
may help to improve radiotherapy treatments delivered to other patients in the future. The 
two extra CT scans that you receive for this project will be used in conjunction with the 
normal treatment planning CT scan and used to assess the effect of organ motion. The 
images from the CT scan will then be used to create a three-dimensional model. This model 
will display the region scanned. (Such as lungs, liver, kidneys and the tumour) The radiation 
dose received by the tumour region and the surrounding tissue for end-expiration and end-
inspiration will be calculated, and will be compared to values obtained from the planning 
scan. 
Copies of all information collected will be kept securely in the office of the Geelong 
Oncology Trials Group, Andrew Love Cancer Centre for a minimum of 15 years. Only staff 
directly involved in this trial will have access to these records. After 15 years, the 
documents may be destroyed, subject to local regulations at that time. The Barwon Health 
Research and Ethics Advisory Committee will be notified before any records are destroyed. 
 
PATIENTS RIGHTS 
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You may ask questions regarding this trial, and you can expect clear and understandable 
answers in return. 
Participation in this project is entirely voluntary. You are free to withdraw your consent 
before or during the project without comment or penalty. Under no circumstances will your 
treatment be affected by your decision. Your withdrawal will not influence any involvement 
(present or future) you may have with the Queensland University of Technology or the 
Andrew Love Cancer Centre. 
A copy of the results obtained from your participation in the study will be sent to you, after 
publication of the Researcher’s Masters thesis, if requested. 
 
ADDITIONAL COSTS 
 
In the unlikely event that you suffer an injury as a result of participating in this trial, hospital 
care and treatment will be provided free of charge. 
 
CONFIDENTIALITY 
 
When the results of this study are published, we will ensure that you will remain 
anonymous.  
 
 
INQUIRIES and CONTACTS 
 
Questions about this project are welcome at any time. Please direct them to Guy Jenetsky. 
Phone: (03) 5226 7869. 
 
The Andrew Love Cancer Centre requires that all participants be informed that if they have 
a medical complaint related to this research study, it may be given to the researcher or Dr 
Rod Lynch (03) 5226 7856.  
For an independent patient representative contact Ms Jill Linklater, Executive Director 
Nursing, Deputy Chief Executive on (03) 5226 7216. 
 
ACKNOWLEDGEMENT 
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you could inform one of the investigators of your decision. 
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Guy Jenetsky 
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Appendix A-5  Patient Consent Form 
Andrew Love Cancer Centre 
Patient Consent Form 
The Effect of Organ Motion on Radiotherapy Plans. 
 
The investigators conducting this research project abide by the rules and principles governing the ethical 
conduct of research and, at all times, avow to protect the interests, comfort and safety of all subjects. 
 
This form and the accompanying Subject Information package have been given to you for your own 
protection. They contain an outline of the experimental procedures and possible risks. 
Your signature below will indicate that: 
 
1) you have received the Subject Information and that you have read its contents; 
2) you clearly understand the procedures and possible risks involved; and that you have been 
given the opportunity to discuss the contents of the Subject Information with one of the 
investigators prior to the commencement of the procedure; 
3) you understand that all the data which you have provided will only be revealed to the 
investigators and yourself. When the results of the study are published, you will remain 
anonymous; 
4) your participation is voluntary and therefore may be terminated at any moment by you without 
comment or penalty; 
5) you may direct any inquires and further questions to Guy Jenetsky at the Andrew Love 
Cancer Centre on (03) 52267869.   
6) you agree to participate in the experimental procedures set out in the Subject Information 
Package  for the research project entitled “The Effect of Organ Motion on Radiotherapy 
Plans” as part of a postgraduate thesis for a Masters (by Research) degree for  Guy Jenetsky.  
Name of Patient    
    
    
Signature of Patient  Date:  
    
    
Name of Witness    
    
    
Signature of Witness  Date:  
    
    
I, (investigator’s name)  have explained the nature 
and purpose of the study to the patient 
    
    
Signature of Investigator  Date:  
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